Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Tricida, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Deficiency
- market value
- Rules
- 5450(b)(2)(C)
Exact text from the filing
December 8, 2022, Tricida received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company was not in compliance with Nasdaq’s Listing Rule 5450(b)(2)(C), as the market value of publicly held shares (the “MVPHS”) for the Company’s common stock had been below the minimum MVPHS requirement of $15,000,000 for 30 consecutive business days (the “MVPHS Requirement”). The notice has no immediate effect on the listing or trading of the Company’s common stock, which will continue to be listed and traded on the Nasdaq Global Select Market, subject to the Company’s compliance with the other Nas
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Tricida, Inc. terminated Manufacturing and Commercial Supply Agreement with Patheon Austria GmbH & Co KG valued at Alleged termination notice for material breach of Manufacturing and Commercial Supply Agreement (effective 2022-12-07).
- Action
- termination
- Agreement
- supply
- Counterparty
- Patheon Austria GmbH & Co KG
- Value
- Alleged termination notice for material breach of Manufacturing and Commercial Supply Agreement
- Effective
- 2022-12-07
Exact text from the filing
On December 7, 2022, Tricida, Inc. (“Tricida”) received notice from Patheon Austria GmbH & Co KG (“Patheon”) alleging that Tricida was in material breach of the Manufacturing and Commercial Supply Agreement, effective October 4, 2019 (as amended by amendment no. 1 dated March 30, 2021, amendment no. 2 dated August 26, 2021, amendment no. 3 dated July 1, 2022, and amendment no. 4 dated September 15, 2022 collectively the “Agreement”) between Tricida and Patheon.
View on SEC.gov